
No Stock Yet
Loading...
No Stock Yet
No Data
Short Volatility Alert: Calithera Biosciences
On Tuesday, shares of Calithera Biosciences (NASDAQ:CALA) experienced volatile short activity. After the activity, the stock price went up 1.95% to $0.2192. The overall sentiment for CALA has been Bu
Calithera to Present at the H.C. Wainwright Global Investment Conference
SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan M
12 Health Care Stocks Moving In Monday's Pre-Market Session
 Gainers Athenex (NASDAQ:ATNX) shares increased by 30.5% to $0.62 during Monday's pre-market session. The market value of their outstanding shares is at $69.1 million. As per the press release, Q1 e
Signals from Technical Perspective: Calithera Biosciences, Inc. (NASDAQ:CALA), Verizon Communications Inc. (NYSE:VZ)
Calithera Biosciences, Inc. (CALA) with the stream of 42.77% also noticed, India Verizon Communications Inc. (VZ) encountered a rapid change of 0.25% in the last hour of trading session. Calithera B
12 Health Care Stocks Moving In Friday's Pre-Market Session
 Gainers Calithera Biosciences (NASDAQ:CALA) shares increased by 37.2% to $0.22 during Friday's pre-market session. The market value of their outstanding shares is at $24.7 million. The company's, Q
Top Premarket Gainers
08:11 AM EDT, 05/13/2022 (MT Newswires) -- Pyxis Tankers (PXS) shares rose more than three fold in premarket trading Friday ahead of its Q1 earnings Monday and after an 8% decline in the previous sess
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Calithera Biosciences (NASDAQ:CALA) shares moved upwards by 29.7% to $0.21 during Thursday's after-market session. Today's trading volume for this security ended up closing at 1.3 million shar
Calithera Biosciences stock slips after PT cut at Ladenburg
Calithera Biosciences (NASDAQ:CALA) stock plunges after Ladenburg analyst Aydin Huseynov lowered the price target to $1.50 from $3 and maintains a Buy rating on the shares after its Q1 results. The c
Calithera Biosciences stock price target cut to $1.50 from $3.00 at Ladenburg Thalmann
Calithera Biosciences stock price target cut to $1.50 from $3.00 at Ladenburg Thalmann
Calithera Biosciences Is Maintained at Equal-Weight by Wells Fargo
Calithera Biosciences Is Maintained at Equal-Weight by Wells Fargo